VIR BIOTECHNOLOGY INC's ticker is VIR and the CUSIP is 92764N102. A total of 224 filers reported holding VIR BIOTECHNOLOGY INC in Q2 2023. The put-call ratio across all filers is 1.94 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $842,129 | -88.2% | 89,875 | -69.0% | 0.00% | -86.7% |
| Q2 2023 | $7,122,433 | -9.4% | 290,356 | -14.0% | 0.02% | -11.8% |
| Q1 2023 | $7,857,627 | +0.6% | 337,672 | +9.4% | 0.02% | -5.6% |
| Q4 2022 | $7,812,514 | +14.9% | 308,673 | -12.5% | 0.02% | +5.9% |
| Q3 2022 | $6,801,000 | +27.3% | 352,733 | +68.2% | 0.02% | +41.7% |
| Q2 2022 | $5,341,000 | +89.5% | 209,709 | +91.4% | 0.01% | +140.0% |
| Q1 2022 | $2,818,000 | +582.3% | 109,570 | +1053.6% | 0.01% | +400.0% |
| Q3 2021 | $413,000 | -33.5% | 9,498 | -21.6% | 0.00% | 0.0% |
| Q1 2021 | $621,000 | -16.1% | 12,111 | -43.8% | 0.00% | 0.0% |
| Q3 2020 | $740,000 | – | 21,543 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bill & Melinda Gates Foundation | 1,559,142 | $30,100,000 | 23.79% |
| SB INVESTMENT ADVISERS (UK) LTD | 22,086,280 | $425,823,000 | 3.26% |
| Zebra Capital Management LLC | 40,104 | $773,000 | 2.94% |
| UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 130,409 | $2,514,000 | 0.94% |
| CLARK ESTATES INC/NY | 180,000 | $3,470,000 | 0.77% |
| Temasek Holdings (Private) Ltd | 6,036,821 | $116,389,909 | 0.70% |
| SECTOR GAMMA AS | 89,808 | $1,731,000 | 0.45% |
| Capital Impact Advisors, LLC | 13,196 | $360,000 | 0.36% |
| SummerHaven Investment Management, LLC | 24,927 | $481,000 | 0.33% |
| DUALITY ADVISERS, LP | 92,712 | $1,787,000 | 0.20% |